[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Liu B.D., Aly M., Hsin-Ti Lin C., Panesar N., Hill H., Qureshi K
How Food Companies Are Changing Products Naturally, as more people start taking GLP-1 medications, fast food and snack aisle sales will continue to drop
In clinical contexts, GSH capsules may aid in managing conditions linked to oxidative imbalance, such as neurodegenerative disorders (e.g., Alzheimer's and Parkinson's disease), liver diseases (e.g., non-alcoholic fatty liver disease), and respiratory ailments (e.g., chronic obstructive pulmonary disease)
A reasonable estimate, based on how tirzepatide moved, is FDA submission in late 2026 and a decision in late 2027
Such calls may startle predators and give green frogs a better chance to escape